Indivior (LON:INDV) Stock Price Down 17% – Should You Sell?

Indivior PLC (LON:INDV) shares were down 17% on Thursday . The stock traded as low as GBX 548.71 ($6.90) and last traded at GBX 720.60 ($9.07). Approximately 2,904,792 shares changed hands during trading, an increase of 294% from the average daily volume of 737,710 shares. The stock had previously closed at GBX 868 ($10.92).

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group reissued a “buy” rating and set a GBX 1,800 ($22.65) price target on shares of Indivior in a research report on Tuesday, December 17th.

Indivior Stock Performance

The company has a current ratio of 0.83, a quick ratio of 1.52 and a debt-to-equity ratio of -170.06. The business’s 50 day moving average is GBX 928.06 and its two-hundred day moving average is GBX 853.71. The company has a market cap of £1.18 billion, a PE ratio of -624.35, a PEG ratio of -5.57 and a beta of 0.19.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.